Sumithra Jeganathan, - Medicare Obstetrics & Gynecology in York, PA

Sumithra Jeganathan, is a medicare enrolled "Obstetrics & Gynecology - Maternal & Fetal Medicine" physician in York, Pennsylvania. Her current practice location is 35 Monument Rd Ste 202, York, Pennsylvania. You can reach out to her office (for appointments etc.) via phone at (717) 851-2722.

Sumithra Jeganathan is licensed to practice in Pennsylvania (license number MD477323) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1013398460.

Contact Information

Sumithra Jeganathan,
35 Monument Rd Ste 202,
York, PA 17403-5074
(717) 851-2722
(717) 851-3127



Physician's Profile

Full NameSumithra Jeganathan
GenderFemale
SpecialityObstetrics & Gynecology - Maternal & Fetal Medicine
Location35 Monument Rd Ste 202, York, Pennsylvania
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1013398460
  • Provider Enumeration Date: 06/11/2015
  • Last Update Date: 08/22/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0648650556
  • Enrollment ID: I20220709000900

Medical Identifiers

Medical identifiers for Sumithra Jeganathan such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013398460NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207VM0101XObstetrics & Gynecology - Maternal & Fetal Medicine MD477323 (Pennsylvania)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sumithra Jeganathan allows following entities to bill medicare on her behalf.
Entity NameYork Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1326060492
PECOS PAC ID: 2961307467
Enrollment ID: O20031205000629

News Archive

Researchers develop a process to tag cancer cells

Scientists label cells with coloured or glowing chemicals to observe how basic cellular activities differ between healthy and cancerous cells. Existing techniques for labelling cells are either too slow or too toxic to perform on live cells. Now, a study reviewed by Philip Dawson, a member of Faculty of 1000 Biology and leading authority in chemistry and cell biology, describes a novel labelling technique that uses a chemical reaction to make live cancer cells light up quickly and safely.

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Gateway Apothecary in St. Louis, Mo., has received a Peter M. Fox Excellence in HIV Credentialing Award for 2014. Gateway was the only pharmacy to be recognized among the 17 nationwide award recipients, which consist primarily of physicians and/or medical practices.

Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research

Roche announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of gene expression and genetic variation, in advanced cancer research.

Call for every health insurance plan to cover Phenylketonuria

Credit Senators John Kerry (D-MA) and Robert Casey (D-PA) with a significant contribution to the health care debate: a bill ends a glaring disparity in the way Americans living with Phenylketonuria (PKU) control their potentially devastating disease, and the way others living with serious chronic conditions are treated. "The Medical Foods Equity Act of 2009" aims to save affected families thousands of dollars in out-of-pocket costs, cut long-term costs for the entire system, and offer 20,000 Americans a better shot at healthy, happy, and productive lives.

Talecris granted EU orphan drug designation for Plasmin (human) to treat acute peripheral arterial occlusion

Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.

Read more Medical News

› Verified 7 days ago

Entity NameWellspan Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750480299
PECOS PAC ID: 1951213115
Enrollment ID: O20040220000815

News Archive

Researchers develop a process to tag cancer cells

Scientists label cells with coloured or glowing chemicals to observe how basic cellular activities differ between healthy and cancerous cells. Existing techniques for labelling cells are either too slow or too toxic to perform on live cells. Now, a study reviewed by Philip Dawson, a member of Faculty of 1000 Biology and leading authority in chemistry and cell biology, describes a novel labelling technique that uses a chemical reaction to make live cancer cells light up quickly and safely.

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Gateway Apothecary in St. Louis, Mo., has received a Peter M. Fox Excellence in HIV Credentialing Award for 2014. Gateway was the only pharmacy to be recognized among the 17 nationwide award recipients, which consist primarily of physicians and/or medical practices.

Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research

Roche announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of gene expression and genetic variation, in advanced cancer research.

Call for every health insurance plan to cover Phenylketonuria

Credit Senators John Kerry (D-MA) and Robert Casey (D-PA) with a significant contribution to the health care debate: a bill ends a glaring disparity in the way Americans living with Phenylketonuria (PKU) control their potentially devastating disease, and the way others living with serious chronic conditions are treated. "The Medical Foods Equity Act of 2009" aims to save affected families thousands of dollars in out-of-pocket costs, cut long-term costs for the entire system, and offer 20,000 Americans a better shot at healthy, happy, and productive lives.

Talecris granted EU orphan drug designation for Plasmin (human) to treat acute peripheral arterial occlusion

Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sumithra Jeganathan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sumithra Jeganathan,
3421 Concord Rd,
York, PA 17402-9001

Ph: (717) 851-3127
Sumithra Jeganathan,
35 Monument Rd Ste 202,
York, PA 17403-5074

Ph: (717) 851-2722

News Archive

Researchers develop a process to tag cancer cells

Scientists label cells with coloured or glowing chemicals to observe how basic cellular activities differ between healthy and cancerous cells. Existing techniques for labelling cells are either too slow or too toxic to perform on live cells. Now, a study reviewed by Philip Dawson, a member of Faculty of 1000 Biology and leading authority in chemistry and cell biology, describes a novel labelling technique that uses a chemical reaction to make live cancer cells light up quickly and safely.

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Gateway Apothecary in St. Louis, Mo., has received a Peter M. Fox Excellence in HIV Credentialing Award for 2014. Gateway was the only pharmacy to be recognized among the 17 nationwide award recipients, which consist primarily of physicians and/or medical practices.

Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research

Roche announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of gene expression and genetic variation, in advanced cancer research.

Call for every health insurance plan to cover Phenylketonuria

Credit Senators John Kerry (D-MA) and Robert Casey (D-PA) with a significant contribution to the health care debate: a bill ends a glaring disparity in the way Americans living with Phenylketonuria (PKU) control their potentially devastating disease, and the way others living with serious chronic conditions are treated. "The Medical Foods Equity Act of 2009" aims to save affected families thousands of dollars in out-of-pocket costs, cut long-term costs for the entire system, and offer 20,000 Americans a better shot at healthy, happy, and productive lives.

Talecris granted EU orphan drug designation for Plasmin (human) to treat acute peripheral arterial occlusion

Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.

Read more News

› Verified 7 days ago


Obstetrics & Gynecology Doctors in York, PA

Dr. Michael Paul Russo, MD
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 4222 Lincoln Hwy, York, PA 17406
Phone: 717-812-7800    Fax: 717-812-7811
Dr. Jahnea Chanel Williams, MD
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 1001 S George St, York, PA 17403
Phone: 717-812-4602    Fax: 717-812-3499
Katherine Nicole Prowell, DO
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 1693 S Queen St, York, PA 17403
Phone: 717-845-1621    
Dr. Norman F. Navarro, MD
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 1000 S George St, York, PA 17403
Phone: 717-851-2348    Fax: 717-851-2426
Kelley D. Clark, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 35 Monument Rd Ste 202, York, PA 17403
Phone: 717-851-2722    Fax: 717-851-3127
Dr. Gretchen Eh Makai, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 2860 Whiteford Rd Unit 1, York, PA 17402
Phone: 717-988-8170    Fax: 717-221-5398

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.